{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:27:25Z","timestamp":1762882045846,"version":"3.45.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05013-8","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:33:01Z","timestamp":1748403181000},"page":"6161-6171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of transjugular intrahepatic portosystemic shunt creation for the management of portal hypertension complications in cancer patients"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-3848","authenticated-orcid":false,"given":"Mohammad Mahdi","family":"Khavandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariman","family":"Nezami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alda L","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketan Y","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno C","family":"Odisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armeen","family":"Mahvash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D","family":"Kuban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul A","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiman","family":"Habibollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"5013_CR1","doi-asserted-by":"publisher","unstructured":"Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clin Proc. 2019;94(4):714\u2013726. https:\/\/doi.org\/10.1016\/j.mayocp.2018.12.020","DOI":"10.1016\/j.mayocp.2018.12.020"},{"issue":"3","key":"5013_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14740\/jmc3630","volume":"12","author":"MC Fuentes-Lacouture","year":"2021","unstructured":"Fuentes-Lacouture MC, Barrera-Garavito EC, Gomez A, Mantilla W. Non-Cirrhotic Portal Hypertension in a Patient With Colonic Carcinoma Treated With Oxaliplatin. J Med Cases. 2021;12(3):99\u2013101. https:\/\/doi.org\/10.14740\/jmc3630","journal-title":"J Med Cases"},{"issue":"9","key":"5013_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ajh.24798","volume":"92","author":"CR Reilly","year":"2017","unstructured":"Reilly CR, Babushok DV, Martin K, et al. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol. 2017;92(9):909\u2013914. https:\/\/doi.org\/10.1002\/ajh.24798","journal-title":"Am J Hematol"},{"issue":"11","key":"5013_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.7326\/0003-4819-126-11-199706010-00002","volume":"126","author":"JP Cello","year":"1997","unstructured":"Cello JP, Ring EJ, Olcott EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med. 1997;126(11):858\u2013865. https:\/\/doi.org\/10.7326\/0003-4819-126-11-199706010-00002","journal-title":"Ann Intern Med"},{"issue":"3","key":"5013_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/gut.48.3.390","volume":"48","author":"G Pomier-Layrargues","year":"2001","unstructured":"Pomier-Layrargues G, Villeneuve JP, Desch\u00eanes M, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut. 2001;48(3):390\u2013396. https:\/\/doi.org\/10.1136\/gut.48.3.390","journal-title":"Gut"},{"issue":"9058","key":"5013_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/s0140-6736(96)08189-5","volume":"349","author":"M R\u00f6ssle","year":"1997","unstructured":"R\u00f6ssle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet Lond Engl. 1997;349(9058):1043\u20131049. https:\/\/doi.org\/10.1016\/s0140-6736(96)08189-5","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"5013_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/hep.20559","volume":"41","author":"TD Boyer","year":"2005","unstructured":"Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatol Baltim Md. 2005;41(2):386\u2013400. https:\/\/doi.org\/10.1002\/hep.20559","journal-title":"Hepatol Baltim Md"},{"issue":"25","key":"5013_CR8","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garc\u00eda-Pag\u00e1n","year":"2010","unstructured":"Garc\u00eda-Pag\u00e1n JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370\u20132379. https:\/\/doi.org\/10.1056\/NEJMoa0910102","journal-title":"N Engl J Med"},{"issue":"3","key":"5013_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hep.20364","volume":"40","author":"F Salerno","year":"2004","unstructured":"Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatol Baltim Md. 2004;40(3):629\u2013635. https:\/\/doi.org\/10.1002\/hep.20364","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"5013_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12876-023-03047-0","volume":"23","author":"A Fichtl","year":"2023","unstructured":"Fichtl A, Seufferlein T, Zizer E. Risks and benefits of TIPS in HCC and other liver malignancies: a literature review. BMC Gastroenterol. 2023;23(1):403. https:\/\/doi.org\/10.1186\/s12876-023-03047-0","journal-title":"BMC Gastroenterol"},{"issue":"23","key":"5013_CR11","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M R\u00f6ssle","year":"2000","unstructured":"R\u00f6ssle M, Ochs A, G\u00fclberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342(23):1701\u20131707. https:\/\/doi.org\/10.1056\/NEJM200006083422303","journal-title":"N Engl J Med"},{"issue":"6","key":"5013_CR12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.510250611","volume":"25","author":"FD Gordon","year":"1997","unstructured":"Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatol Baltim Md. 1997;25(6):1366\u20131369. https:\/\/doi.org\/10.1002\/hep.510250611","journal-title":"Hepatol Baltim Md"},{"issue":"5","key":"5013_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00042737-200105000-00011","volume":"13","author":"V Siegerstetter","year":"2001","unstructured":"Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, R\u00f6ssle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13(5):529\u2013534. https:\/\/doi.org\/10.1097\/00042737-200105000-00011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"5013_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/jhep.2002.30274","volume":"35","author":"A Perell\u00f3","year":"2002","unstructured":"Perell\u00f3 A, Garc\u00eda-Pag\u00e1n JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatol Baltim Md. 2002;35(1):132\u2013139. https:\/\/doi.org\/10.1053\/jhep.2002.30274","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"5013_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/01.rvi.0000064846.87207.ab","volume":"14","author":"M Wallace","year":"2003","unstructured":"Wallace M, Swaim M. Transjugular intrahepatic portosystemic shunts through hepatic neoplasms. J Vasc Interv Radiol JVIR. 2003;14(4):501\u2013507. https:\/\/doi.org\/10.1097\/01.rvi.0000064846.87207.ab","journal-title":"J Vasc Interv Radiol JVIR"},{"issue":"3","key":"5013_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5604\/01.3001.0011.7392","volume":"17","author":"V Cruz-Ram\u00f3n","year":"2018","unstructured":"Cruz-Ram\u00f3n V, Chinchilla-L\u00f3pez P, Ram\u00edrez-P\u00e9rez O, et al. Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients. Ann Hepatol. 2018;17(3):476\u2013481. https:\/\/doi.org\/10.5604\/01.3001.0011.7392","journal-title":"Ann Hepatol"},{"issue":"4 Pt 1","key":"5013_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","volume":"72","author":"HO Conn","year":"1977","unstructured":"Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72(4 Pt 1):573\u2013583.","journal-title":"Gastroenterology"},{"issue":"1","key":"5013_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","volume":"70","author":"GP Aithal","year":"2021","unstructured":"Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9\u201329. doi:https:\/\/doi.org\/10.1136\/gutjnl-2020-321790","journal-title":"Gut"},{"key":"5013_CR19","doi-asserted-by":"publisher","unstructured":"Bureau C, Larrue H, Cortes-Cerisuleo M, et al. EASL Clinical Practice Guidelines on TIPS. J Hepatol. 2025;0(0). https:\/\/doi.org\/10.1016\/j.jhep.2025.01.029","DOI":"10.1016\/j.jhep.2025.01.029"},{"issue":"2","key":"5013_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u2013460. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"issue":"1","key":"5013_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/apt.12994","volume":"41","author":"D Bettinger","year":"2015","unstructured":"Bettinger D, Kn\u00fcppel E, Euringer W, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2015;41(1):126\u2013136. https:\/\/doi.org\/10.1111\/apt.12994","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"5013_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s00270-024-03766-1","volume":"47","author":"MM Khavandi","year":"2024","unstructured":"Khavandi MM, Habibollahi P. Trans-splenic Sharp Recanalization, Extra-Anatomic Portal Vein Reconstruction, and Intrahepatic Portosystemic Shunt creation for the Treatment of Portal Hypertension in a Patient with Polycythemia Vera and JAK2 Mutation. Cardiovasc Intervent Radiol. 2024;47(8):1148\u20131151. https:\/\/doi.org\/10.1007\/s00270-024-03766-1","journal-title":"Cardiovasc Intervent Radiol"},{"key":"5013_CR23","doi-asserted-by":"publisher","unstructured":"Berger JM, Preusser M, Berghoff AS, Bergen ES. Malignant ascites: Current therapy options and treatment prospects. Cancer Treat Rev. 2023;121. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102646","DOI":"10.1016\/j.ctrv.2023.102646"},{"issue":"6","key":"5013_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/hepr.12162","volume":"44","author":"L Liu","year":"2014","unstructured":"Liu L, Zhao Y, Qi X, et al. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res Off J Jpn Soc Hepatol. 2014;44(6):621\u2013630. https:\/\/doi.org\/10.1111\/hepr.12162","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"issue":"6","key":"5013_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(6):550\u2013558. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"5013_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.dld.2014.04.009","volume":"46","author":"A De Santis","year":"2014","unstructured":"De Santis A, Iegri C, Kondili L, et al. Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: a retrospective case-control study. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2014;46(8):726\u2013730. https:\/\/doi.org\/10.1016\/j.dld.2014.04.009","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"5","key":"5013_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","volume":"59","author":"M R\u00f6ssle","year":"2013","unstructured":"R\u00f6ssle M. TIPS: 25 years later. J Hepatol. 2013;59(5):1081\u20131093. https:\/\/doi.org\/10.1016\/j.jhep.2013.06.014","journal-title":"J Hepatol"},{"issue":"1","key":"5013_CR28","doi-asserted-by":"publisher","first-page":"12893","DOI":"10.1038\/s41598-024-63608-5","volume":"14","author":"HK Chon","year":"2024","unstructured":"Chon HK, Lee YC, Kim TH, Lee SO, Kim SH. Revolutionizing outcomes: endoscopic ultrasound-guided gallbladder drainage using innovative electrocautery enhanced-lumen apposing metal stents for high-risk surgical patients. Sci Rep. 2024;14(1):12893. https:\/\/doi.org\/10.1038\/s41598-024-63608-5","journal-title":"Sci Rep"},{"issue":"1","key":"5013_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40644-022-00451-9","volume":"22","author":"H Yan","year":"2022","unstructured":"Yan H, Qiu Z, Xiang Z, Feng K, Huang M, Gao F. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience. Cancer Imaging. 2022;22(1):13. https:\/\/doi.org\/10.1186\/s40644-022-00451-9","journal-title":"Cancer Imaging"},{"issue":"1","key":"5013_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1148\/radiol.2311030967","volume":"231","author":"H Ferral","year":"2004","unstructured":"Ferral H, Gamboa P, Postoak DW, et al. Survival after Elective Transjugular Intrahepatic Portosystemic Shunt Creation: Prediction with Model for End-Stage Liver Disease Score. Radiology. 2004;231(1):231\u2013236. https:\/\/doi.org\/10.1148\/radiol.2311030967","journal-title":"Radiology"},{"issue":"5","key":"5013_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5152\/dir.2019.18416","volume":"25","author":"MP Perell\u00f3","year":"2019","unstructured":"Perell\u00f3 MP, Mur JP, Vives MS, et al. Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft. Diagn Interv Radiol. 2019;25(5):346\u2013352. https:\/\/doi.org\/10.5152\/dir.2019.18416","journal-title":"Diagn Interv Radiol"},{"issue":"5","key":"5013_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000495944","volume":"8","author":"A Hiraoka","year":"2019","unstructured":"Hiraoka A, Michitaka K, Kumada T, et al. Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan. Liver Cancer. 2019;8(5):403\u2013411. https:\/\/doi.org\/10.1159\/000495944","journal-title":"Liver Cancer"},{"issue":"6","key":"5013_CR33","doi-asserted-by":"publisher","first-page":"e1209-e1217","DOI":"10.1097\/SLA.0000000000003803","volume":"274","author":"YY Wang","year":"2021","unstructured":"Wang YY, Xiang BD, Ma L, et al. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma. Ann Surg. 2021;274(6):e1209-e1217. https:\/\/doi.org\/10.1097\/SLA.0000000000003803","journal-title":"Ann Surg"},{"issue":"5","key":"5013_CR34","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/jcm13051412","volume":"13","author":"S Shalaby","year":"2024","unstructured":"Shalaby S, Miraglia R, Senzolo M. Transjugular Intrahepatic Portosystemic Shunt in Nonmalignant Noncirrhotic Portal Vein Thrombosis and Portosinusoidal Vascular Disorder. J Clin Med. 2024;13(5):1412. https:\/\/doi.org\/10.3390\/jcm13051412","journal-title":"J Clin Med"},{"issue":"5","key":"5013_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/PPO.0000000000000683","volume":"29","author":"JJ Waninger","year":"2023","unstructured":"Waninger JJ, Ma VT, Chopra Z, Pearson AN, Green MD. Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis. Cancer J Sudbury Mass. 2023;29(5):279\u2013284. https:\/\/doi.org\/10.1097\/PPO.0000000000000683","journal-title":"Cancer J Sudbury Mass"},{"issue":"3","key":"5013_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/hep.27407","volume":"61","author":"D Thabut","year":"2015","unstructured":"Thabut D, Rudler M, Dib N, et al. Multicenter prospective validation of the Baveno IV and Baveno II\/III criteria in cirrhosis patients with variceal bleeding. Hepatol Baltim Md. 2015;61(3):1024\u20131032. https:\/\/doi.org\/10.1002\/hep.27407","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"5013_CR37","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","volume":"13","author":"P Tandon","year":"2015","unstructured":"Tandon P, Abraldes JG, Keough A, et al. Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child-Pugh Class, and Effects of Antibiotics. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2015;13(6):1189\u20131196.e2. https:\/\/doi.org\/10.1016\/j.cgh.2014.11.019","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"5013_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G-T Guadalupe. Guadalupe","year":"2017","unstructured":"Guadalupe. Guadalupe G-T, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology. 2017;65;310\u201335.","journal-title":"Hepatology"},{"issue":"2","key":"5013_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/cncr.20367","volume":"101","author":"MJ Wallace","year":"2004","unstructured":"Wallace MJ, Madoff DC, Ahrar K, Warneke CL. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting. Cancer. 2004;101(2):337\u2013345. https:\/\/doi.org\/10.1002\/cncr.20367","journal-title":"Cancer"},{"issue":"4","key":"5013_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ajg.2016.29","volume":"111","author":"S Nardelli","year":"2016","unstructured":"Nardelli S, Gioia S, Pasquale C, et al. Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Am J Gastroenterol. 2016;111(4):523\u2013528. https:\/\/doi.org\/10.1038\/ajg.2016.29","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5013_CR41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.26684","volume":"59","author":"P Berlioux","year":"2014","unstructured":"Berlioux P, Robic MA, Poirson H, et al. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatol Baltim Md. 2014;59(2):622\u2013629. https:\/\/doi.org\/10.1002\/hep.26684","journal-title":"Hepatol Baltim Md"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05013-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:23:33Z","timestamp":1762881813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05013-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5013"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05013-8","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Cnflict of interest"}}]}}